Want to see HK:2160 full AI Analyst Report?

MicroPort CardioFlow Medtech Corp. (2160) Ratios

2 Followers

MicroPort CardioFlow Medtech Corp. Ratios

HK:2160's free cash flow for Q4 2025 was $0.34. For the 2025 fiscal year, HK:2160's free cash flow was decreased by $ and operating cash flow was $-0.48. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	2.53	2.52	3.86	10.55	12.82
Quick Ratio	-1.60	1.93	3.55	9.91	12.17
Cash Ratio	3.29	0.47	0.25	5.50	10.53
Solvency Ratio	-0.08	-0.03	-0.05	-1.64	-1.76
Operating Cash Flow Ratio	-0.16	-0.02	-0.26	-1.07	-1.03
Short-Term Operating Cash Flow Coverage	-1.22	-0.18	-2.98	0.00	0.00
Net Current Asset Value	$ -44.77M	HK$ -313.05M	$ 1.22B	$ 1.80B	$ 2.02B
Leverage Ratios
Debt-to-Assets Ratio	0.35	0.35	0.03	0.03	0.03
Debt-to-Equity Ratio	0.13	0.91	0.04	0.03	0.03
Debt-to-Capital Ratio	0.11	0.48	0.03	0.03	0.03
Long-Term Debt-to-Capital Ratio	0.09	0.42	<0.01	0.00	0.00
Financial Leverage Ratio	0.37	2.61	1.22	1.10	1.09
Debt Service Coverage Ratio	-0.43	-0.80	-2.92	-100.64	-67.66
Interest Coverage Ratio	-9.59	-59.12	-16.59	-80.12	-72.59
Debt to Market Cap	0.36	0.54	0.03	0.00	0.00
Interest Debt Per Share	2.75	3.68	0.17	0.03	0.04
Net Debt to EBITDA	34.77	-11.35	0.28	2.58	5.09
Profitability Margins
Gross Profit Margin	54.65%	64.97%	69.48%	68.39%	64.59%
EBIT Margin	-27.07%	-34.51%	-38.13%	-136.72%	-145.74%
EBITDA Margin	-1.85%	-25.14%	-31.34%	-114.82%	-138.60%
Operating Profit Margin	-27.20%	-22.78%	-17.32%	-93.29%	-150.02%
Pretax Profit Margin	-31.92%	-31.62%	-12.79%	-137.88%	-179.78%
Net Profit Margin	-33.30%	-32.99%	-13.68%	-140.25%	-181.02%
Continuous Operations Profit Margin	-33.31%	-33.00%	-14.73%	-140.25%	-181.02%
Net Income Per EBT	104.31%	104.35%	106.88%	101.72%	100.69%
EBT Per EBIT	117.36%	138.79%	73.88%	147.80%	119.84%
Return on Assets (ROA)	-19.67%	-2.81%	-1.85%	-18.30%	-15.14%
Return on Equity (ROE)	-6.69%	-7.35%	-2.26%	-20.20%	-16.50%
Return on Capital Employed (ROCE)	-20.62%	-2.49%	-2.79%	-13.16%	-13.33%
Return on Invested Capital (ROIC)	-19.73%	-2.38%	-2.72%	-13.00%	-13.19%
Return on Tangible Assets	40.73%	-3.57%	-1.99%	-18.32%	-16.01%
Earnings Yield	-116.34%	-4.92%	-3.31%	-13.59%	-8.33%
Efficiency Ratios
Receivables Turnover	0.62	0.63	2.11	3.33	4.54
Payables Turnover	0.69	0.53	2.77	2.00	1.86
Inventory Turnover	0.29	0.23	0.82	0.87	0.78
Fixed Asset Turnover	0.55	0.56	0.71	1.71	1.04
Asset Turnover	0.59	0.09	0.14	0.13	0.08
Working Capital Turnover Ratio	0.48	0.46	0.23	0.17	0.11
Cash Conversion Cycle	1.29K	1.49K	489.36	348.74	353.09
Days of Sales Outstanding	584.45	579.68	173.20	109.64	80.36
Days of Inventory Outstanding	1.24K	1.59K	447.77	421.96	468.55
Days of Payables Outstanding	531.54	682.48	131.62	182.87	195.81
Operating Cycle	1.82K	2.17K	620.97	531.61	548.91
Cash Flow Ratios
Operating Cash Flow Per Share	-0.26	-0.05	-0.24	-0.09	-0.08
Free Cash Flow Per Share	-5.77	-0.61	-0.58	-0.10	-0.10
CapEx Per Share	5.51	0.55	0.34	0.01	0.02
Free Cash Flow to Operating Cash Flow	22.27	11.53	2.42	1.15	1.27
Dividend Paid and CapEx Coverage Ratio	-0.05	-0.09	-0.71	-6.78	-3.72
Capital Expenditure Coverage Ratio	-0.05	-0.09	-0.71	-6.78	-3.72
Operating Cash Flow Coverage Ratio	-0.10	-0.01	-1.45	-2.94	-1.91
Operating Cash Flow to Sales Ratio	-0.06	-0.06	-0.31	-0.62	-0.73
Free Cash Flow Yield	-90.18%	-10.00%	-18.08%	-6.85%	-4.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-0.86	-20.17	-30.21	-7.36	-12.00
Price-to-Sales (P/S) Ratio	1.43	6.71	4.13	10.32	21.72
Price-to-Book (P/B) Ratio	0.06	1.49	0.68	1.49	1.98
Price-to-Free Cash Flow (P/FCF) Ratio	-1.11	-10.00	-5.53	-14.60	-23.54
Price-to-Operating Cash Flow Ratio	-4.94	-115.29	-13.38	-16.76	-29.87
Price-to-Earnings Growth (PEG) Ratio	<0.01	-0.01	0.34	-1.40	-0.08
Enterprise Value Multiple	-42.51	-38.03	-12.91	-6.41	-10.58
Enterprise Value	346.24M	4.24B	1.46B	2.47B	3.68B
EV to EBITDA	-42.51	-38.03	-12.91	-6.41	-10.58
EV to Sales	0.79	9.56	4.05	7.36	14.66
EV to Free Cash Flow	-0.61	-14.25	-5.42	-10.42	-15.89
EV to Operating Cash Flow	-13.58	-164.31	-13.10	-11.95	-20.17
Tangible Book Value Per Share	-8.33	1.80	4.34	0.99	1.10
Shareholders’ Equity Per Share	20.25	4.05	4.68	0.99	1.16
Tax and Other Ratios
Effective Tax Rate	-0.04	-0.04	-0.15	-0.02	>-0.01
Revenue Per Share	4.47	0.90	0.77	0.14	0.11
Net Income Per Share	-1.49	-0.30	-0.11	-0.20	-0.19
Tax Burden	1.04	1.04	1.07	1.02	1.01
Interest Burden	1.18	0.92	0.34	1.01	1.23
Research & Development to Revenue	0.15	0.25	0.42	0.71	0.89
SG&A to Revenue	0.67	0.67	0.62	0.21	0.29
Stock-Based Compensation to Revenue	>-0.01	0.01	0.03	0.04	0.06
Income Quality	0.18	0.18	2.41	0.45	0.40